• Moderators, please send me a PM if you are unable to access mod permissions. Thanks, Habsy.

Hey Nerds: Blockchain

Monday morning gap up. Will probably sell my COST calls and chill.

Hopefully, MSOs join the bull parade today.
Bid-asks on MSOs still feeling weak. Still think we need to drop another 5-10% at least before demand increases again. Just isn't an appetite for buyers right now after such a strong run-up.

But it's certainly worth nibbling away on them still. Let's get it.
 
  • Like
Reactions: CH1
COME ON THUMB! LETS GET SOME FUCKING FOLLOW THROUGH! LESS BEAR FLAGS, MORE BULLISH MOMO! Macro conditions are trying to help but the correlation to SPX is so ridiculously bearish. Not a great sign by any means but these things can change on a dime. Short interest on these names have skyrocketed and the daily chart in all honesty looks bullish as fuck. We have everything we need to produce tremendous amounts of fireworks.. Except buyers at the moment.

Shorting after 20-25% pullbacks on these names is a dangerous game. Could drop a lot more but this could be one giant daily bull flag in the making.
 
LETS FUCKING GO THUMB! GIVE ME MORE VOLUME THAN THIS!!! DAILY BEAR FLAG OR BULLISH REVERSAL? GIVE IT TO ME STRAIGHT BROTHER!! IT'S FEELING BEAR FLAGGY RIGHT NOW!!!
 
Curaleaf approaching a couple of KEY resistances while Thumb pulls back harshly. I've got my money on a rejection.

~$11 psychological, ~11.05 and ~11.20 some key levels for The Leaf.


It all feels quite weak so unless we bust through these key resistances another leg down is fully in play.
 
AAPL hit $515 today on another analyst upgrade. I'm not short but I thinks that's the high for a while. Now at $501. I did buy QQQ puts with my SHOP profits.

Stop on QQQ puts is now break even. I might be wrong and the market can certainly rip higher but the risk/reward is too good to pass up here.

Plus my favourite contra indicator said today was the start of a multi year bull rally.
 
It's really quite remarkable. The guy promotes himself as a master chartist, and often blocks people who disagree with him.
 
And how the fuck are you going to predict things that happen over the next decade? Really? I don't even agree with predictions in a month, much less a decade.
 
  • Like
Reactions: CH1
I never really loved TERs short-term SP outlook. Still holding up fairly well but there could be more downside there as the rest of the sector is consolidating and they really haven't yet.

Some things to look out for regarding TER in the mid to long term:

So their market cap is about $1.2b US and are currently at a $140m annual revenue run rate. Now that is going to grow significantly (potentially will be pulling out 40+% QOQ growth for the next 2-3 quarters and if NJ legalizes it'll get even better) AND being profitable/cash flow positive is enormous, but not sure they are discounted compared to other names out there. Remember, they are on the hook for $175m in cash considerations for their Ilera acquisition in PA due in early 2021. They currently have under $53m in cash and Ilera may take shares in the end, but either way dilution is likely coming. There's another x-factor in case of US federal legalization... Canopy will almost CERTAINLY acquire them. And it won't be a cheap acquisition. But that's a bit of a prayer at this point. I don't think that's coming anytime soon.

I think I'm going to hold off on them for now and stick to the big boys that already pulled back 20-30% from highs. Still like them and I'm absolutely all over their upcoming growth and if I get enough of a dip I'll be back.. But I definitely liked them a lot better when they were priced at ~$2.80.
 
  • Like
Reactions: CH1
Ultimately if there's a sector-wide bull hype run TER will get a huge move too, maybe a touch smaller as they have consolidated less than the others. They'll all run together. But long-term I think I like the upside of the big boys a bit better just because of their larger footprints. TER is pricing in a lot of growth right now too which just adds a bit of risk on them (though being profitable and highly present two large growth markets makes them a lot less risky for now - their short term growth is pretty much guaranteed). And short to mid-term there will be almost guaranteed dilution which may not be a big deal... I'd just rather avoid it if I can. There's just a lot o and pros and cons to TER. A lot less straight forward than playing the bigger names right now. But that could mean greater upside too. A mature and legal PA and NJ and they may be quadrupling revenues within a year. All of a sudden that's a big fucking discount. But my main point is that green thumb/Cresco will be discounted too if/when that happens. Even moreso probably as you can price in more growth with them when those two states are legal and mature as they have a wider footprint that isn't entirely dependant on those two states.

Tldr: buy drug stocks. They're clearly hard for the market to price but they still shouldn't be this cheap.
 
Back
Top